Robert John Feczko, MD
Plastic and Reconstructive Surgery · Greenville
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 12 years
- University of Washington School of Medicine, 2014
Offices
1 location · Vidant Medical Group LLC · 986 clinicians in this group
Hospitals listed: Ecu Health Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Feczko’s office at (252) 816-6000 to ask if they take your plan before you enroll.
California Medical Board record
Licence A168853 · Delinquent
Licence status: Delinquent · since 2020 · expires 2022-05-31 · University of Washington School of Medicine.
License renewal fee has not been paid. No practice is permitted.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Ecu Health Medical CenterGreenville, NCAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of ECU Health, which runs 9 hospitalsPatients rate it 3 of 5 · 68% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — Pressure ulcer rate: 1.19 (0.83 to 1.55) · 16,246 cases, Jul 2022 – Jun 2024Better than the national rate — Postoperative respiratory failure rate: 3.06 (0 to 6.63) · 1,886 cases, Jul 2022 – Jun 2024Better than the national rate — Postoperative sepsis rate: 2.68 (0.21 to 5.16) · 1,526 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.535, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.51, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.285, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 1,649 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Ecu Health Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 1 worse of 8 measures. Safety: 1 better, 7 the same, 0 worse of 8 measures. Readmissions: 1 better, 5 the same, 5 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Pressure ulcer rateComplications and deaths | 1.19 (0.83 to 1.55) · 16,246 cases | Worse | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 3.06 (0 to 6.63) · 1,886 cases | Better | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 2.68 (0.21 to 5.16) · 1,526 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.535 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.51 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.285 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 1,649 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.04 (0.29 to 1.78) · 3,705 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.88 (0.69 to 1.07) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 203.82 (172.06 to 235.58) · 283 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.1 · 349 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.1 · 320 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13 · 649 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 13.4 · 1,190 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.1 · 837 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.6 · 990 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 8,450 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0.02 to 0.33) · 18,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.11 to 0.44) · 18,666 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.34 (2.94 to 5.74) · 4,732 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.7 (0 to 1.82) · 1,910 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.41 (0.33 to 2.48) · 4,512 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.72 (0.44 to 3) · 1,148 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 161 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0.907 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.907 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.293 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.5 · 996 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.3 · 2,015 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -11 · 700 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 18 · 1,351 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 17.4 · 839 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.8 · 1,192 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.8 (3.5 to 6.5) · 427 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.5 (10.1 to 15.2) · 427 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 7.7 · 171 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.1 · 411 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.9 · 545 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.7 (11.3 to 19.2) · 874 cases | No different | Jan 2022 – Dec 2024 |
What patients said (4,679 patients answered, 18% of those asked)
| Cleanliness | 2 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 63% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 68% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 57% |
| "YES", patients would definitely recommend the hospital | 68% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
Original Medicare doctor bills
$7,959
Medicare paid this office $7,959 for 27 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures Medicare counted
| Melanoma (skin cancer) excision | 1-10 | None |
| Removal of tissue | 1-10 | None |
Who their Medicare patients are
27 Original Medicare patients in 2024. Average age 77 · Women 41% · Health risk score 1.93. Above the middle of the specialty; the typical plastic and reconstructive surgery clinician is at 1.21.
Conditions among them: High blood pressure 75% · Chronic kidney disease 59% · Diabetes 48% · Coronary heart disease 44%.
The office billed $30,428, Medicare allowed $10,278 and paid $7,959; for 74 services of 30 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 27 | 74 | 77 | 1.93 | $30,428 | $7,959 |
| 2023 | 56 | 167 | 71 | 1.94 | $95,161 | $22,629 |
| 2022 | 67 | 153 | 69 | 2.07 | $122,510 | $29,835 |
| 2021 | 15 | 27 | 74 | 1.62 | $16,600 | $5,354 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Return visit (30+ min) | 14 | $1,146 | $72 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 14 | $880 | $63 |
| Short return visit (20+ min) | 12 | $748 | $53 |
Medicaid work
$8,212 in 2024
Medicaid paid $8,212 for 134 billed services this clinician did in 2024, up to 22 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| New patient visit (30+ min) | 101 | $8,212 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 33 | $0 |
| 2024 | 134 | 2 | 22 | $8,212 |
| 2023 | 42 | 1 | 14 | $3,468 |
See the largest Medicaid services in earlier years
2023
| New patient visit (30+ min) | 42 | $3,468 |
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 67% of their 27 Part D prescriptions in 2019. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Year by year
| 2019 | 27 | 24 | 67% (18) | None | $107 |
| 2018 | 20 | 15 | 85% (17) | 0% | $96 |
| 2017 | 21 | 14 | None | None | $597 |
| 2016 | 56 | 17 | 0% (0) | None | $2,198 |
| 2015 | 11 | None | 0% (0) | None | $787 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2019: 1 drug
| Oxycodone | 14 | $59 | $4 |
2018: 1 drug
| Oxycodone | 15 | $87 | $6 |
Money from drug and device companies
$1,675 in 2025
| 2025 | 13 | 17 | None | $1,675 |
| 2024 | 6 | 13 | None | $690 |
| 2023 | 9 | 43 | None | $6,869 |
| 2022 | 6 | 15 | None | $2,578 |
| 2021 | 4 | 17 | None | $1,395 |
| 2020 | 2 | 4 | None | $432 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Aroa Biosurgery | None | $504 | 2 payments
|
| DePuy Synthes Sales | VA-Lcp | $264 | 2 payments
|
| Musculoskeletal Transplant Foundation | None | $167 | 1 payment
|
| Davol | Arista | $156 | 2 payments
|
| Innovation Technologies | Irrisept | $109 | 1 payment
|
| KLS-Martin L.P. | None | $101 | 1 payment
|
See all 17 published payments
| Davol | Meals · 2025-12-16 | Arista | $150 |
| Davol | Education · 2025-12-16 | Arista | $7 |
| Aroa Biosurgery | Meals · 2025-12-16 | None | $2 |
| Musculoskeletal Transplant Foundation | Meals · 2025-12-03 | None | $167 |
| Smith+Nephew | Meals · 2025-11-19 | Grafix Pl | $22 |
| Access Pro Medical | Meals · 2025-11-10 | Matriderm | $68 |
| MIMEDX Group | Meals · 2025-11-04 | None | $31 |
| Solventum | Meals · 2025-10-14 | V.A.C. Veraflo | $87 |
| TELA Bio | Meals · 2025-10-07 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) | $29 |
| PolyMedics Innovations | Meals · 2025-09-10 | None | $53 |
| Axogen | Meals · 2025-07-31 | None | $59 |
| Innovation Technologies | Meals · 2025-07-28 | Irrisept | $109 |
| KLS-Martin L.P. | Meals · 2025-07-22 | None | $101 |
| Smith+Nephew | Meals · 2025-06-24 | Stravix | $26 |
| DePuy Synthes Sales | Meals · 2025-06-16 | VA-Lcp | $140 |
| Aroa Biosurgery | Meals · 2025-03-24 | None | $501 |
| DePuy Synthes Sales | Meals · 2025-01-15 | Trumatch | $124 |
See earlier years (2024, 2023, 2022, 2021, 2020)
2024: $690
| Mentor Worldwide | Mentor Memorygel Resterilizable Gel Sizer | $229 | 4 payments
|
| KLS-Martin L.P. | None | $178 | 3 payments
|
| Musculoskeletal Transplant Foundation | None | $177 | 2 payments
|
| Kerecis | Kerecis Omega3 Surgiclose | $57 | 1 payment
|
| Urgo Medical North America | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap | $32 | 2 payments
|
| Solventum | V.A.C. Veraflo | $17 | 1 payment
|
2023: $6,869
| Medical Device Business Services | None | $2,990 | 9 payments
|
| Axogen | Avance Nerve Graft | $2,893 | 5 payments
|
| DePuy Synthes Sales | Na | $258 | 3 payments
|
| KLS-Martin L.P. | None | $191 | 3 payments
|
| Abbvie | Revolve | $138 | 4 payments
|
| Stryker | Na | $130 | 1 payment
|
| Mentor Worldwide | Artoura Breast Tissue Expander | $124 | 2 payments
|
| Musculoskeletal Transplant Foundation | None | $122 | 2 payments
|
| Organogenesis | Puraply | $24 | 1 payment
|
2022: $2,578
| Medical Device Business Services | None | $2,018 | 8 payments
|
| Integra LifeSciences | Integra | $140 | 1 payment
|
| DePuy Synthes Sales | Trumatch | $125 | 1 payment
|
| KLS-Martin L.P. | None | $124 | 2 payments
|
| Mentor Worldwide | Artoura Breast Tissue Expander | $89 | 2 payments
|
| Musculoskeletal Transplant Foundation | None | $81 | 1 payment
|
2021: $1,395
| Stryker | Na | $495 | 2 payments
|
| KLS-Martin L.P. | None | $475 | 12 payments
|
| Medical Device Business Services | None | $400 | 2 payments
|
| DePuy Synthes Sales | Trumatch | $25 | 1 payment
|
2020: $432
| Medical Device Business Services | None | $410 | 2 payments
|
| KLS-Martin L.P. | None | $22 | 2 payments
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 98.3 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1942629753
- Licence
- CA A168853California A168853: Delinquent · expires 2022-05-31
- Trained
- University of Washington School of Medicine, 2014 · 12 years ago
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 208200000X (208200000X)
- Mailing address
- 1000 Welch Rd Ste 100, Palo Alto, CA, 94304
- NPI first listed
- 2014-04-09
- NPI last updated
- 2020-07-13
- NPI record certified
- 2020-07-13
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 500 University Dr, Hershey, PA, 17033